Status:
UNKNOWN
Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response
Lead Sponsor:
Riyadh Fertility and Reproductive Health center
Conditions:
Infertility, Female
Eligibility:
FEMALE
35-42 years
Phase:
PHASE2
Brief Summary
In this study, the investigators will assess the efficacy of growth hormone co-stimulation to GnRH antagonist regimen in poor responders to COH for IVF.
Detailed Description
To date, a limited number of studies have been performed in order to assess whether the addition of GH can improve the probability of pregnancy in poor responders undergoing ovarian stimulation for IV...
Eligibility Criteria
Inclusion
- Serum anti-Müllerian hormone (AMH) less than 1.2 ng/ml
Exclusion
- \-
Key Trial Info
Start Date :
November 29 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2020
Estimated Enrollment :
228 Patients enrolled
Trial Details
Trial ID
NCT03373149
Start Date
November 29 2017
End Date
November 1 2020
Last Update
May 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Riyadh Fertility and Reproductive Health center
Giza, Egypt